CD Protein Inhibitors  >>  Phase 1


«12345678910111213»
Download options
                                                                                                      
 Phase 
N/A
1
2
3
4
 Trials
 012345678910
            
            
             
BIIB063 / Biogen           
          
            
             
BJ-005 / BJ Biosci           
          
            
             
BMS-986090 / BMS           
          
            
             
BMS-986358 / BMS           
          
            
             
BMS-986406 / BMS, Ono Pharma           
          
            
             
BMS-986497 / BMS           
          
            
             
BND-35 / Biond Biologics           
          
            
             
BPI-371153 / Betta Pharma           
          
            
             
BSI-038 / Biosion, Sino Biopharm           
          
            
             
BT-007 / Bioceltech           
          
            
             
BYK324677 / Takeda           
          
            
             
BYON4413 / Byondis           
          
            
             
CA-170 / Curis           
          
            
             
CAR-NK-CD19 cells / Beijing Boren Hospital           
          
            
             
CAR-T19/CAR-T22 immunotherapy / Shenzhen BinDeBio           
          
            
             
CAR20.19.22 T / Miltenyi Biotec, Medical College of Wisconsin           
          
            
             
CART-33 / University of Pennsylvania           
          
            
             
CART-meso-19 T cells / Novartis           
          
            
             
CB-010 / Caribou Biosci           
          
            
             
CC-96191 / BMS           
          
            
             
CCW702 / AbbVie           
          
            
             
CCX559 / Amgen           
          
            
             
CD123-CAR T cell therapy / St. Jude Children's Research Hospital           
          
            
             
CD123R(EQ)28zeta/EGFRt+ T cells / National Cancer Institute           
          
            
             
CD147-CAR T cells / Peking University People's Hospital           
          
            
             
CD19 UCART cells / China Biotech Services           
          
            
             
CD19-CAR-DNT / Ruichuang Bio, Zhejiang Ruijiamei Biotech           
          
            
             
CD19-CAR.CD45RA- negative T-cells / St. Jude Children's Research Hospital           
          
            
             
CD19-CD34 CAR transduced T cells / Loyola University           
          
            
             
CD19/CD20 CAR T-cells / PersonGen Biomedicine           
          
            
             
CD19/CD22 dual target CAR T / Beijing Boren Hospital           
          
            
             
CD19x22 CAR T / University of Colorado           
          
            
             
CD20-CD19 cCAR T cells / iCell Gene Therap           
          
            
             
CD22-targeted CAR-T cell therapy / PersonGen Biomedicine           
          
            
             
CD33 CAR-T / Alaunos Therap, Precigen           
          
            
             
CD38-SADA / Y-mAbs Therap           
          
            
             
CD40.HIVRI.Env / ANRS           
          
            
             
CD5 CAR T (CT125B) / Beijing Boren Hospital           
          
            
             
CD7-UCAR-γδT cells / PersonGen Biomedicine           
          
            
             
CD79b CAR-T cell therapy / Shanghai Yake Biotech           
          
            
             
CDX-527 / Celldex           
          
            
             
CDX-585 / Celldex           
          
            
             
CHECKvacc (CF33-hNIS-antiPDL1) / Imugene           
          
            
             
CHS-1000 / Coherus Biosci           
          
            
             
CID-103 / CASI, Precision Autoimmune Therap           
          
            
             
CLDN18.2/CD19 targeted CAR-T / Innovative Cellular Therapeutics           
          
            
             
CLL1+CD33 CAR-T / Hedy Group, Zhejiang University           
          
            
             
CLL1-CD33 cCART cell therapy / iCell Gene Therap           
          
            
             
CLN-049 / Cullinan Therap           
          
            
             
CLN-978 / Cullinan Therap           
          
            
            


«12345678910111213»